Arcturus Therapeutics Holdings Inc (NASDAQ:ARCT)

23.78
Delayed Data
As of Dec 08
 -0.23 / -0.96%
Today’s Change
14.21
Today|||52-Week Range
37.75
+40.21%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Quarter 1
2019
Revenue and IncomeNet Revenues0.000.0013.0M4.4M
 
 
 
Depreciation And Amortization15.0K41.0K332.0K172.0K
 
 
 
 
 
 
Operating ExpensesGross Income-15.0K-41.0K12.7M4.2M
 
 
 
 
 
General Expenses3.8M2.9M13.7M10.7M
 
 
 
 
 
Research And Development1.4M1.1M11.4M7.3M
 
 
 
 
 
Total Operating Expenses3.8M2.9M14.0M10.9M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-3.8M-2.9M-144.0K-6.5M
 
 
 
 
 
Interest Expense On Debt0.000.00810.0K203.0K
 
 
 
Equity In Earnings0.000.000.00-288.0K
 
 
Other Expenses0.00232.0K-232.0K0.00
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-3.7M-2.5M-1.2M-6.6M
 
 
 
 
 
Income Taxes-12.0K-27.0K-50.0K0.00
 
 
 
 
Net Income-3.7M-2.6M-1.1M-6.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS3.9M3.9M10.7M10.1M
 
 
 
 
 
Shares To Calculate EPS Diluted3.9M3.9M10.7M10.1M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.91-$0.63---$0.68
 
 
 
 
EPS Diluted-$0.91-$0.63-$0.11-$0.68